Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.


BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Asian Markets Rally as Micron and Qualcomm AI Outlook Lifts Global Tech Stocks
Gold Drops Below $4,000 as Strong US Dollar and Fed Rate Hike Expectations Pressure Bullion
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response
SpaceX Eyes Starlink Mobile Phone Service to Challenge Verizon, AT&T, and T-Mobile
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 



